{"id":919,"date":"2019-07-10T10:00:13","date_gmt":"2019-07-10T09:00:13","guid":{"rendered":"https:\/\/bogenommedicinskcannabis.dk\/?page_id=919"},"modified":"2019-07-10T12:19:36","modified_gmt":"2019-07-10T11:19:36","slug":"case-studies-cannabinoider-er-associeret-med-kraefthaemmende-aktivitet1","status":"publish","type":"page","link":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/artikler\/medicinsk-cannabis-og-kraeft\/case-studies-cannabinoider-er-associeret-med-kraefthaemmende-aktivitet1\/","title":{"rendered":"Case Studies: Cannabinoider er associeret med kr\u00e6fth\u00e6mmende aktivitet[1]"},"content":{"rendered":"

Nogle nye studier viser, at CBD kan have kr\u00e6fth\u00e6mmende respons hos mennesker.<\/p>\n

I det f\u00f8rste studie rapporterede britiske forskere om brugen af CBD til en 81-\u00e5rig lungekr\u00e6ftpatient efter at han havde afsl\u00e5et kemobehandling.[2]<\/a> Forfatterne rapporterede, at patientens tumorst\u00f8rrelseblev reduceret efter brug af CBD ekstrakt.<\/p>\n

De konkluderede: \u201dDe data, vi pr\u00e6senterer her indikerer, at CBD kan spille en rolle i den forbavsende respons hos en patient med lungekr\u00e6ft som resultat af selvmedicinering med CBD olie i en m\u00e5ned uden andre former for livsstils\u00e6ndringer, medicin eller kost\u00e6ndringer.\u201d<\/p>\n

I det andet studie, beskrev brasilianske forskere brugen af CBD hos to 38-\u00e5rige patienter med hjernekr\u00e6ft.[3]<\/a> Deres brug af CBD sammen med deres kr\u00e6ftbehandling viste en \u201dsignifikant forbedring\u201d, og der var ingen progression af sygdommen i to \u00e5r.<\/p>\n

Forfatterne konkluderede, at \u201cdisse observationer er s\u00e6rligt interessante, fordi cannabinoidernes farmakologi ser ud til at v\u00e6re forskellige fra de eksisterende kr\u00e6ftpr\u00e6parater og kan vise sig at v\u00e6re en unik og synergistisk mulighed som fremtidig behandling af glioma.\u201d<\/p>\n

Et studie fra 2017 viste, at samtidig brug af CBD og Temozolomide til 21 patienter med glioma hjernekr\u00e6ft rapporterede, at de patienter, der fik CBD i gennemsnit levede 45% l\u00e6ngere end de, der udelukkende var behandlet med Temozolomide.[4]<\/a><\/p>\n

Selvom cannabinoider har veldokumenteret kr\u00e6fth\u00e6mmende aktivitet i pr\u00e6-kliniske studier, har forskere generelt ikke haft held til at fastsl\u00e5 disse egenskaber i kontrollerede, kliniske fors\u00f8g.[5]<\/a><\/p>\n

\"\"<\/p>\n

[1]<\/a> Case Studies: Cannabinoids Associated With Anti-Cancer Activity<\/a>. https:\/\/norml.org\/news\/2019\/03\/14\/case-studies-cannabinoids-associated-with-anti-cancer-activity<\/a><\/p>\n

[2]<\/a> Josep Sul\u00e9-Suso<\/a>,1,2<\/sup> Nick A Watson<\/a>,3<\/sup> Daniel G van Pittius<\/a> et al.: Striking lung cancer response to self-administration of cannabidiol: A case report and literature review. SAGE Open Med Case Rep<\/a>. 2019; 7: 2050313X19832160.<\/p>\n

Published online 2019 Feb 21. doi:\u00a010.1177\/2050313X19832160<\/a><\/p>\n

https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6385325\/<\/a><\/p>\n

[3]<\/a> Paula B. Dall’Stella<\/a>1*<\/sup>, Marcos F. L. Docema1<\/sup>, Marcos V. C. Maldaun<\/a> et al.: Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol. Front. Oncol., 18 January 2019 | https:\/\/doi.org\/10.3389\/fonc.2018.00643<\/a> https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2018.00643\/full<\/a><\/p>\n

[4]<\/a> GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in<\/p>\n

Glioma. http:\/\/ir.gwpharm.com\/static-files\/cde942fe-555c-4b2f-9cc9-f34d24c7ad27<\/a><\/p>\n

5]<\/a> Gliomas\/Cancer. https:\/\/norml.org\/library\/item\/gliomascancer<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Nogle nye studier viser, at CBD kan have kr\u00e6fth\u00e6mmende respons hos mennesker. I det f\u00f8rste studie rapporterede britiske forskere om brugen af CBD til en 81-\u00e5rig lungekr\u00e6ftpatient efter at han havde afsl\u00e5et kemobehandling.[2] Forfatterne rapporterede, at patientens tumorst\u00f8rrelseblev reduceret efter … L\u00e6s resten →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":306,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-919","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/comments?post=919"}],"version-history":[{"count":1,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/919\/revisions"}],"predecessor-version":[{"id":921,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/919\/revisions\/921"}],"up":[{"embeddable":true,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/306"}],"wp:attachment":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/media?parent=919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}